| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2020 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Sell | 890,700 | $7.70 | $6,862,424.05 | -4.7% | |
| Nov 10, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 10,000 | $0.30 | $2,950.00 | - | |
| Nov 9, 2020 | MRK Merck & Co., Inc. | Frazier Kenneth C | Chairman, President &CEO | Sell | 280,000 | $81.42 | $22,797,011.35 | -22.4% | |
| Nov 9, 2020 | IRWD Ironwood Pharmaceuticals Inc | Kilroy Conor | SVP, GC &Secretary | Sell | 836 | $10.92 | $9,129.12 | -0.3% | |
| Nov 9, 2020 | IRWD Ironwood Pharmaceuticals Inc | Rickard Jason65 | SVP, Chief Operating Officer | Sell | 394 | $10.92 | $4,302.48 | -0.2% | |
| Nov 9, 2020 | PFE Pfizer Inc | Susman Sally | Executive Vice President | Sell | 43,662 | $41.94 | $1,831,184.28 | -28.8% | |
| Nov 9, 2020 | IRWD Ironwood Pharmaceuticals Inc | Consylman Gina | SVP, CFO &Treasurer | Sell | 1,415 | $10.92 | $15,451.80 | -0.3% | |
| Nov 9, 2020 | PFE Pfizer Inc | Bourla Albert | Chairman &CEO | Sell | 132,508 | $41.94 | $5,557,385.52 | -62.9% | |
| Nov 9, 2020 | PRGO Perrigo Co Plc | Classon Rolf A | Director | Buy | 2,137 | $46.75 | $99,897.91 | +24.5% | |
| Nov 9, 2020 | ANIP Ani Pharmaceuticals Inc | Walsh Patrick D52 | Director | Buy | 5,000 | $25.96 | $129,800.00 | +16.6% | |
| Nov 9, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Patrick Gregory S | Sr. VP Chief Financial Officer | Sell | 5,000 | $25.00 | $125,000.00 | -10.1% | |
| Nov 9, 2020 | PRGO Perrigo Co Plc | Samuels Theodore R. II51 | Director | Buy | 4,500 | $46.91 | $211,112.10 | +33.0% | |
| Nov 9, 2020 | IRWD Ironwood Pharmaceuticals Inc | MacDonald Kelly | Chief Accounting Officer | Sell | 2,797 | $11.14 | $31,161.00 | -1.0% | |
| Nov 9, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 63,723 | $0.28 | $17,720.60 | - | |
| Nov 6, 2020 | TLRY Tilray Brands, Inc. | St.clare Christine | Director | Sell | 4,400 | $10.05 | $44,233.20 | -19.1% | |
| Nov 6, 2020 | TLRY Tilray Brands, Inc. | Dopp Rebekah | Director | Sell | 4,812 | $10.00 | $48,120.00 | -20.8% | |
| Nov 6, 2020 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | President And CEO | Sell | 400,000 | $9.88 | $3,953,291.12 | -1.0% | |
| Nov 6, 2020 | CRON Cronos Group Inc. | Gorenstein Michael Ryan77 | Executive Chairman | Sell | 1,289,350 | $7.23 | $9,315,945.85 | -49.0% | |
| Nov 5, 2020 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | President And CEO | Sell | 400,000 | $7.43 | $2,973,567.95 | -2.0% | |
| Nov 5, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Patrick Gregory S | Sr. VP, CFO | Sell | 5,000 | $23.00 | $115,000.00 | -10.1% | |
| Nov 4, 2020 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | President And CEO | Sell | 400,000 | $6.04 | $2,415,200.00 | -3.8% | |
| Nov 3, 2020 | ESPR Esperion Therapeutics, Inc. | Biotech Target N V55 | 10% Owner | Buy | 200,000 | $25.31 | $5,062,120.00 | +5.3% | |
| Nov 3, 2020 | GTBIF Green Thumb Industries Inc. | Kadens Peter A. | 10% Owner | Sell | 1,250,000 | $14.82 | $18,526,250.00 | -100.0% | |
| Nov 3, 2020 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 40,000 | $90.59 | $3,623,600.00 | -1.7% | |
| Nov 2, 2020 | NBIX Neurocrine Biosciences Inc | Benevich Eric62 | Chief Commercial Officer | Sell | 20,595 | $96.53 | $1,987,971.51 | -57.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.